Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma

NCT03797170 is registered in ClinicalTrials.gov with University of Bologna as lead sponsor.

NCT NCT03797170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03797170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma
Lead sponsor
University of Bologna
Phase
Observational
Overall status
Unknown status
Start date
April 2, 2019
Completion date
December 20, 2023
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma